欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0694/001
药品名称Daptomycin 350mg powder for solution for injection or infusion
活性成分
    • daptomycin 350.0 mg
剂型Powder for concentrate for solution for infusion/injection
上市许可持有人Xellia Pharmaceuticals ApS Slavonska avenija 24/6 Zagreb Croatia 1000
参考成员国 - 产品名称Ireland (IE)
PA1982/003/001
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      Daptomycin Rotexmedica 350 mg Pulver zur Herstellung einer Injektions- bzw. Infusionslösung
    • Austria (AT)
      Daptomycin Panpharma 350 mg Pulver zur Herstellung einer Injektions-/Infusionslösung
    • France (FR)
    • Spain (ES)
    • Italy (IT)
许可日期2017/08/24
最近更新日期2023/03/31
药物ATC编码
    • J01XX09 daptomycin
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase